放射性心脏毒性的核医学影像方法
乳腺癌放疗可致心肌灌注与血流改变,进而引发冠心病、心肌病和心力衰竭。本文综述SPECT门控采集评估左室收缩与舒张功能、SPECT心肌灌注显像、PET定量心肌血流量,以及评估炎症和心脏交感神经去支配的PET与SPECT示踪剂,并讨论新型核医学影像在早期发现放疗相关心功能异常中的潜在应用。
要点
- 放疗心脏毒性先表现为心肌灌注和血流改变,早期检出有助于阻止病理生理进展。
- SPECT门控采集可评估左室收缩与舒张功能,SPECT心肌灌注显像常用99mTc-sestamibi和99mTc-tetrofosmin。
- PET定量心肌血流因部分示踪剂摄取与心肌血流量近乎线性关系而非常准确,另有PET与SPECT示踪剂可评估炎症和心脏交感神经去支配。
核心结论
- 核医学影像技术可用于评估放疗所致机械性心功能障碍的长期效应,新型核医学影像在评估部分受照射乳腺癌患者心功能障碍早期征象方面有前景。
研究设计与样本
- 本文为综述,检索范围未在摘要中报告。
主要发现
- 放疗可在细胞水平损伤心肌结构,最终导致冠心病和(非)缺血性心肌病等多种心血管问题并引发心力衰竭。
- 这些心脏并发症出现前先有心肌灌注和血流的改变,早期检出这些改变对阻止病理生理进展很重要。
- SPECT门控采集可评估左室收缩与舒张功能;SPECT心肌灌注显像使用99mTc-sestamibi和99mTc-tetrofosmin等放射性药物。
- PET可准确定量心肌血流量,因部分用于PET心肌血流量测量的示踪剂摄取与心肌血流量几乎呈线性关系。
- 有PET和SPECT示踪剂可评估心脏炎症和心脏交感神经系统的去支配。
关键数值与推荐
- 部分早期研究显示,因左侧乳腺癌接受放疗的女性比因右侧乳腺癌接受放疗的女性更易发生心脏毒性副作用;这些试验中左侧照射野多采用未行心脏保护技术的较旧放疗技术,包含更大体积的心脏和左心室。
- 过去数十年放疗技术改进使心脏受照剂量和体积持续减少;放疗减少局部区域肿瘤复发和乳腺癌死亡并提高生存,因此多数患者放疗获益超过放疗后极低的心血管不良事件潜在风险。
临床怎么用
- 原文未据此给出推荐。
- 作者指出,过去数十年研究主要集中于左室功能受损和灌注缺损的长期发展。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Breast cancer survival is significantly improved over the past decades due to major improvements in anti-tumor therapies and the implementation of regular screening, which leads to early detection of breast cancer. Therefore, it is of utmost importance to prevent patients from long-term side effects, including radiotherapy-induced cardiotoxicity. Radiotherapy may contribute to damage of myocardial structures on the cellular level, which eventually could result in various types of cardiovascular problems, including coronary artery disease and (non-)ischemic cardiomyopathy, leading to heart failure. These cardiac complications of radiotherapy are preceded by alterations in myocardial perfusion and blood flow. Therefore, early detection of these alterations is important to prevent the progression of these pathophysiological processes. Several radionuclide imaging techniques may contribute to the early detection of these changes. Single-Photon Emission Computed Tomography (SPECT) cameras can be used to create Multigated Acquisition scans in order to assess the left ventricular systolic and diastolic function. Furthermore, SPECT cameras are used for myocardial perfusion imaging with radiopharmaceuticals such as 99mTc-sestamibi and 99mTc-tetrofosmin. Accurate quantitative measurement of myocardial blood flow (MBF), can be performed by Positron Emission Tomography (PET), as the uptake of some of the tracers used for PET-based MBF measurement almost creates a linear relationship with MBF, resulting in very accurate blood flow quantification. Furthermore, there are PET and SPECT tracers that can assess inflammation and denervation of the cardiac sympathetic nervous system. Research over the past decades has mainly focused on the long-term development of left ventricular impairment and perfusion defects. Considering laterality of the breast cancer, some early studies have shown that women irradiated for left-sided breast cancer are more prone to cardiotoxic side effects than women irradiated for right-sided breast cancer. The left-sided radiation field in these trials, which predominantly used older radiotherapy techniques without heart-sparing techniques, included a larger volume of the heart and left ventricle, leading to increased unavoidable radiation exposure to the heart due to the close proximity of the radiation treatment volume. Although radiotherapy for breast cancer exposes the heart to incidental radiation, several improvements and technical developments over the last decades resulted in continuous reduction of radiation dose and volume exposure to the heart. In addition, radiotherapy reduces loco-regional tumor recurrences and death from breast cancer and improves survival. Therefore, in the majority of patients, the benefits of radiotherapy outweigh the potential very low risk of cardiovascular adverse events after radiotherapy. This review addresses existing nuclear imaging techniques, which can be used to evaluate (long-term) effects of radiotherapy-induced mechanical cardiac dysfunction and discusses the potential use of more novel nuclear imaging techniques, which are promising in the assessment of early signs of cardiac dysfunction in selected irradiated breast cancer patients.
引用
- Polomski ES, Antoni ML, Jukema JW, et al. Nuclear medicine imaging methods of radiation-induced cardiotoxicity. Semin Nucl Med. 2022. PMID: 35246310. doi:10.1053/j.semnuclmed.2022.02.001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。